BioNTech and Autolus Join Forces to Accelerate CAR-T Cell Therapies
BioNTech, a next-generation immunotherapy company, and Autolus Therapeutics, a clinical-stage biopharmaceutical company, announced a strategic collaboration on February 8, 2024. The collaboration aims to advance both…